Columbia University Medical Center   discover care educate lead
HDNY.org hdsa center of excellence    
at the NY state psychiatric institute

If you notice any problems with the website, please email site editor.

HSG Collaboration – Publications

As a Huntington Study Group site, investigators and participants from our Center have contributed to the following studes.

Clinical Trials - ARTICLES

  1. Huntington Study Group (Marshall F, primary author).  Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington’s disease.  Neurol 1998;50:1366-1373.
  2. The Huntington Study Group (Kieburtz K, primary author).  A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease.  Neurol 2001;57:397-404.
  3. Huntington Study Group (Marshall F, primary author).  Dosage effects of riluzole in Huntington’s disease: a multicenter placebo-controlled study.  Neurol 2003; 61:1551-1556.
  4. Huntington Study Group (Cudkowicz M, primary author).  Minocycline safety and tolerability in Huntington's disease.  Neurol 2004;63:547-549.
  5. Huntington Study Group, (Marshall F, primary author). Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial. Neurology 2006;66:366-372.
  6. Marshall FJ, Fahn S, Clarence-Smith K (Reply from the authors). Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial. Neurology 2007;68:797.
  7. Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J. A study of chorea after tetrabenazine withdrawal in patients with Huntington’s disease.  Clinical Neuropharmacology (in press).
 
 

Copyright 2000-2009 HDNY.ORG : At NY State Psychiatric Institute
Columbia University Medical Center : Department of Neurology : Last updated 27-Jun-2009